JPWO2023132208A5 - - Google Patents

Info

Publication number
JPWO2023132208A5
JPWO2023132208A5 JP2023572398A JP2023572398A JPWO2023132208A5 JP WO2023132208 A5 JPWO2023132208 A5 JP WO2023132208A5 JP 2023572398 A JP2023572398 A JP 2023572398A JP 2023572398 A JP2023572398 A JP 2023572398A JP WO2023132208 A5 JPWO2023132208 A5 JP WO2023132208A5
Authority
JP
Japan
Prior art keywords
atom
pharmaceutical composition
compound
formula
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572398A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023132208A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/046460 external-priority patent/WO2023132208A1/ja
Publication of JPWO2023132208A1 publication Critical patent/JPWO2023132208A1/ja
Publication of JPWO2023132208A5 publication Critical patent/JPWO2023132208A5/ja
Pending legal-status Critical Current

Links

JP2023572398A 2022-01-07 2022-12-16 Pending JPWO2023132208A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022001547 2022-01-07
PCT/JP2022/046460 WO2023132208A1 (ja) 2022-01-07 2022-12-16 心不全の予防および/または治療用医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023132208A1 JPWO2023132208A1 (https=) 2023-07-13
JPWO2023132208A5 true JPWO2023132208A5 (https=) 2025-12-10

Family

ID=87073543

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572398A Pending JPWO2023132208A1 (https=) 2022-01-07 2022-12-16

Country Status (5)

Country Link
US (1) US20250073229A1 (https=)
EP (1) EP4461296A4 (https=)
JP (1) JPWO2023132208A1 (https=)
CN (1) CN118678955A (https=)
WO (1) WO2023132208A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023276828A1 (ja) * 2021-06-29 2023-01-05 国立大学法人大阪大学 腎障害の予防および/または治療用医薬組成物、並びにオートファジー活性化剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006114706A1 (en) * 2005-04-26 2006-11-02 Pfizer Limited Triazole derivatives as vasopressin antagonists
WO2008054702A1 (en) * 2006-10-31 2008-05-08 Schering Corporation Anilinopiperazine derivatives and methods of use thereof
WO2010022055A2 (en) * 2008-08-20 2010-02-25 Amgen Inc. Inhibitors of voltage-gated sodium channels
EP2356111A1 (en) * 2008-11-10 2011-08-17 Schering Corporation Compounds for the treatment of inflammatory disorders
US9006450B2 (en) * 2010-07-01 2015-04-14 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
ES2968678T3 (es) * 2018-04-27 2024-05-13 Univ Osaka Inhibidores del canal TRPC3 o TRPC6
WO2020102575A1 (en) * 2018-11-16 2020-05-22 Inception Ibd, Inc. Heterocyclic aminothiazoles and uses thereof
JP7594274B2 (ja) 2019-10-24 2024-12-04 国立大学法人大阪大学 難聴の予防および/または治療用医薬組成物

Similar Documents

Publication Publication Date Title
JP2010506942A5 (https=)
US8026254B2 (en) Therapeutic agents useful for treating pain
JP2023531311A5 (https=)
JP2008195730A5 (https=)
JP2008525416A5 (https=)
JP2022545633A5 (https=)
JP2006143737A5 (https=)
JP2013528180A5 (https=)
JP2004524312A5 (https=)
RU2019136361A (ru) Инъекционные составы нейростеорида с замедленным высвобождением
JP2016503797A5 (https=)
JP2010524927A5 (ja) 化合物2−ヒドロキシ−3−[5−(モルホリン−4−イルメチル)ピリジン−2−イル]1h−インドール−5−カルボニトリルの新規な製造方法
JP2011504903A5 (https=)
JP2008526999A5 (https=)
JP2012532883A5 (https=)
DK2968226T3 (en) Oxprenolol Compositions for the Treatment of Cancer
JP2007500734A5 (https=)
JP2021512913A5 (https=)
JP2012525437A5 (https=)
JP2023101521A5 (https=)
JPWO2023132208A5 (https=)
JP2022537140A5 (https=)
JP2007532627A5 (https=)
JP2024510939A5 (https=)
JP2020511450A5 (https=)